Evelo Biosciences Common Stock

Evelo Biosciences (EVLO) currently reports a common stock of $19K as of September 2023. That compares with $110K in the prior-year period — down 82.4% year over year. Use the charts on this page to explore Evelo Biosciences's common stock history and peer comparisons.

Evelo Biosciences's common stock decreased from $110K to $19K — a 82.4% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Evelo Biosciences reported $19K in common stock as of September 2023. That compares with $110K in the prior-year period — down 82.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $19K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Evelo Biosciences, and consider following EVLO for alerts when major investors trade the stock.

Evelo Biosciences is classified in the Healthcare sector. On common stock, it currently shows $19K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EVLO with unrelated industries.